IRIS Accounts Production v23.3.0.418 07305000 director 1.4.22 31.3.23 31.3.23 true false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073050002022-03-31073050002023-03-31073050002022-04-012023-03-31073050002021-03-31073050002021-04-012022-03-31073050002022-03-3107305000ns10:Originalns15:EnglandWales2022-04-012023-03-3107305000ns14:PoundSterlingns10:Original2022-04-012023-03-3107305000ns10:Originalns10:Director12022-04-012023-03-3107305000ns10:Original2022-04-012023-03-3107305000ns10:Original2023-03-3107305000ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3107305000ns10:Originalns10:SmallEntities2022-04-012023-03-3107305000ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3107305000ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3107305000ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3107305000ns10:Originalns10:AbridgedAccounts2022-04-012023-03-3107305000ns10:Originalns10:RegisteredOffice2022-04-012023-03-3107305000ns10:Original2022-03-3107305000ns10:Originalns5:CurrentFinancialInstruments2023-03-3107305000ns10:Originalns5:CurrentFinancialInstruments2022-03-3107305000ns10:Originalns5:Non-currentFinancialInstruments2023-03-3107305000ns10:Originalns5:Non-currentFinancialInstruments2022-03-3107305000ns5:ShareCapitalns10:Original2023-03-3107305000ns5:ShareCapitalns10:Original2022-03-3107305000ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3107305000ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3107305000ns10:Originalns5:PlantMachinery2022-04-012023-03-3107305000ns10:Originalns5:FurnitureFittings2022-04-012023-03-3107305000ns10:Originalns5:ComputerEquipment2022-04-012023-03-3107305000ns10:Original2021-04-012022-03-3107305000ns10:Original2022-03-31
REGISTERED NUMBER: 07305000 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2023

for

Clinica Fiore Ltd

Clinica Fiore Ltd (Registered number: 07305000)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


Clinica Fiore Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTOR: F Refrigeri





REGISTERED OFFICE: 1 Stanyards Courtyard
Stanyards Farm
Chertsey Road
Chobham
Surrey
GU24 8JE





REGISTERED NUMBER: 07305000 (England and Wales)





ACCOUNTANTS: Ahmad York Limited
Chartered Certified Accountants
1 Stanyards Courtyard
Stanyards Farm
Chertsey Road
Chobham
Surrey
GU24 8JE

Clinica Fiore Ltd (Registered number: 07305000)

Abridged Statement of Financial Position
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 10,437 8,359

CURRENT ASSETS
Debtors 14,495 10,000
Cash at bank and in hand 407 20,251
14,902 30,251
CREDITORS
Amounts falling due within one year 227,569 187,808
NET CURRENT LIABILITIES (212,667 ) (157,557 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(202,230

)

(149,198

)

CREDITORS
Amounts falling due after more than one
year

(21,702

)

(31,955

)

PROVISIONS FOR LIABILITIES (2,044 ) (1,588 )
NET LIABILITIES (225,976 ) (182,741 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (226,076 ) (182,841 )
SHAREHOLDERS' FUNDS (225,976 ) (182,741 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Clinica Fiore Ltd (Registered number: 07305000)

Abridged Statement of Financial Position - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the year ended 31 March 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 31 January 2024 and were signed by:





F Refrigeri - Director


Clinica Fiore Ltd (Registered number: 07305000)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Clinica Fiore Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% on reducing balance

Financial instruments
The company only enters into basic financial instrument transactions in accordance with Section 11. Financial assets and liabilities are measured at cost and financial assets are assessed at the end of each reporting period for objective evidence of impairment.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Clinica Fiore Ltd (Registered number: 07305000)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2022 - 4 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2022 83,119
Additions 5,663
At 31 March 2023 88,782
DEPRECIATION
At 1 April 2022 74,760
Charge for year 3,585
At 31 March 2023 78,345
NET BOOK VALUE
At 31 March 2023 10,437
At 31 March 2022 8,359

5. SECURED DEBTS

An amount of up to £10,000 and all monies due or to become due from the Company are secured via a rent deposit deed.

6. RELATED PARTY DISCLOSURES

The accounts include a loan from a shareholder where interest has not been charged and therefore has not been concluded under normal market conditions. The loan held at the year end was £91,820 (2021: £91,820).

7. GOING CONCERN

The ability of the company to continue as a going concern depends on the continued financial support of its director and shareholders who to date have given no indication that this support will be withdrawn in the immediate future.